Faculty Profiles - ANDO Yuichi

Papers - ANDO Yuichi

Division display 41 - 60 of about 124 ／ All the affair displays >>

Clinical impact of standardized creatinine on dose adjustment of capecitabine

Ito, A; Ichikawa, K; Miyazaki, M; Sagara, A; Motegi, T; Ando, Y; Senzaki, K; Nagai, T; Yamada, K

NAGOYA JOURNAL OF MEDICAL SCIENCE Vol. 84 ( 3 ) page： 547 - 553 2022.8

Direct Observation of Retinal Microvessels in Cancer Patients After Systemic Administration of Bevacizumab and Oxaliplatin.

Mitsuma A, Ito Y, Shimokata T, Tanaka C, Uehara K, Nakayama G, Terasaki H, Ando Y

Cancer diagnosis & prognosis Vol. 2 ( 3 ) page： 330 - 335 2022.5

Increased Risk of Thyroid Dysfunction by PD-1 and CTLA-4 Blockade in Patients Without Thyroid Autoantibodies at Baseline

Iwama, S; Kobayashi, T; Yasuda, Y; Okuji, T; Ito, M; Ando, M; Zhou, X; Yamagami, A; Onoue, T; Kawaguchi, Y; Miyata, T; Sugiyama, M; Takagi, H; Hagiwara, D; Suga, H; Banno, R; Hase, T; Morise, M; Wakahara, K; Yokota, K; Kato, M; Nishio, N; Tanaka, C; Miyata, K; Ogura, A; Ito, T; Sawada, T; Shimokata, T; Niimi, K; Ohka, F; Ishigami, M; Gotoh, M; Hashimoto, N; Saito, R; Kiyoi, H; Kajiyama, H; Ando, Y; Hibi, H; Sone, M; Akiyama, M; Kodera, Y; Arima, H

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM Vol. 107 ( 4 ) page： E1620 - E1630 2022.3

Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade

Miyai, Y; Sugiyama, D; Hase, T; Asai, N; Taki, T; Nishida, K; Fukui, T; Chen-Yoshikawa, TF; Kobayashi, H; Mii, S; Shiraki, Y; Hasegawa, Y; Nishikawa, H; Ando, Y; Takahashi, M; Enomoto, A

LIFE SCIENCE ALLIANCE Vol. 5 ( 6 ) 2022.3

[Chemotherapy for Older Patients with Cancer].

Mitsuma A, Ando Y

Gan to kagaku ryoho. Cancer & chemotherapy Vol. 49 ( 1 ) page： 13 - 18 2022.1

Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer

Takano, Y; Furune, S; Miyai, Y; Morita, S; Inoue, M; Shimokata, T; Sugishita, M; Mitsuma, A; Maeda, O; Ando, Y

INTERNATIONAL CANCER CONFERENCE JOURNAL Vol. 11 ( 1 ) page： 67 - 70 2022.1

Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment (Oct, 10.1007/s13691-021-00515-w, 2021)

Furune, S; Kondo, C; Takano, Y; Shimokata, T; Sugishita, M; Mitsuma, A; Maeda, O; Ando, Y

INTERNATIONAL CANCER CONFERENCE JOURNAL Vol. 11 ( 1 ) page： 49 - 49 2022.1

Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment

Furune, S; Kondo, C; Takano, Y; Shimokata, T; Sugishita, M; Mitsuma, A; Maeda, O; Ando, Y

INTERNATIONAL CANCER CONFERENCE JOURNAL Vol. 11 ( 1 ) page： 46 - 48 2022.1

COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective

Nishiwaki, S; Ando, Y

FRONTIERS IN MEDICINE Vol. 8 page： 812370 2021.12

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial

Kanda, M; Shimizu, D; Miyata, K; Maeda, O; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Ando, M; Kuwatsuka, Y; Murotani, K; Nakayama, G; Koike, M; Ando, Y; Ebata, T; Kodera, Y

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS Vol. 24 page： 100853 2021.12

A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events

Schöffski, P; Concin, N; Suarez, C; Subbiah, V; Ando, Y; Ruan, SL; Wagner, JP; Mansfield, K; Zhu, X; Origuchi, S; DiDominick, S; Bialucha, CU; Faris, JE; Tran, B

ONCOLOGY RESEARCH AND TREATMENT Vol. 44 ( 10 ) page： 547 - 556 2021.10

Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies

Ito, T; Ishigami, M; Yamamoto, T; Mizuno, K; Yamamoto, K; Imai, N; Ishizu, Y; Honda, T; Kawashima, H; Yasuda, S; Toyoda, H; Yokota, K; Hase, T; Nishio, N; Maeda, O; Kato, M; Hashimoto, N; Hibi, H; Kodera, Y; Sone, M; Ando, Y; Akiyama, M; Shimoyama, Y; Fujishiro, M

HEPATOLOGY INTERNATIONAL Vol. 15 ( 5 ) page： 1278 - 1287 2021.10

Prognostic impact of immune-related adverse events on patients with and without cardiovascular disease: a retrospective review

Kazama, S; Morimoto, R; Kimura, Y; Shibata, N; Ozaki, R; Araki, T; Mizutani, T; Oishi, H; Arao, Y; Kuwayama, T; Hiraiwa, H; Kondo, T; Furusawa, K; Shimokata, T; Okumura, T; Bando, YK; Ando, Y; Murohara, T

CARDIO-ONCOLOGY Vol. 7 ( 1 ) page： 26 2021.7

A case of recurrent gastric cancer with drug-induced immune thrombocytopenia caused by trastuzumab

Takano, Y; Furune, S; Morita, S; Inoue, M; Shimokata, T; Sugishita, M; Mitsuma, A; Osamu, M; Ando, Y

ANNALS OF ONCOLOGY Vol. 32 page： S354 - S354 2021.7

Guidelines for clinical evaluation of anti-cancer drugs

Minami, H; Kiyota, N; Kimbara, S; Ando, Y; Shimokata, T; Ohtsu, A; Fuse, N; Kuboki, Y; Shimizu, T; Yamamoto, N; Nishio, K; Kawakami, Y; Nihira, SI; Sase, K; Nonaka, T; Takahashi, H; Komori, Y; Kiyohara, K

CANCER SCIENCE Vol. 112 ( 7 ) page： 2563 - 2577 2021.7

Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

Wick, A; Bähr, O; Schuler, M; Rohrberg, K; Chawla, SP; Janku, F; Schiff, D; Heinemann, V; Narita, Y; Lenz, HJ; Ikeda, M; Ando, Y; Wick, W; Steinbach, JP; Burger, MC; Wenger, K; Lassen, U; Sankhala, KK; Roggia, C; Genvresse, I; Munhoz, C; Rentzsch, C; Reschke, S; Langer, S; Wagner, M; Kaulfuss, S; Cai, C; Lagkadinou, E; Jeffers, M; Peña, C; Tabatabai, G

CLINICAL CANCER RESEARCH Vol. 27 ( 10 ) page： 2723 - 2733 2021.5

Phase I study of the antiprogrammed cell death-1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies

Minami, H; Doi, T; Toyoda, M; Imamura, Y; Kiyota, N; Mitsuma, A; Shimokata, T; Naito, Y; Matsubara, N; Tajima, T; Tokushige, K; Ishihara, K; Cameron, S; Ando, Y

CANCER SCIENCE Vol. 112 ( 2 ) page： 725 - 733 2021.2

Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)

Nakayama, G; Takano, N; Taniguchi, H; Ishigure, K; Yokoyama, H; Teramoto, H; Hashimoto, R; Sakai, M; Ishiyama, A; Kinoshita, T; Hayashi, N; Nakamura, M; Hattori, N; Sato, Y; Umeda, S; Uehara, K; Aiba, T; Sonohara, F; Hayashi, M; Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Koike, M; Fujiwara, M; Murotani, K; Ando, M; Ando, Y; Muro, K; Kodera, Y

EUROPEAN JOURNAL OF CANCER Vol. 144 page： 61 - 71 2021.2

Protocol for a multi-site, cluster-randomized, phase III, comparative clinical trial of geriatric assessment of older patients with non-small-cell lung cancer: the ENSURE-GA study

Tsubata, Y; Shinomiya, S; Inoue, K; Ishikawa, N; Saito, R; Nakashima, K; Hotta, K; Hamada, A; Nagashima, F; Ando, Y; Morita, S; Kobayashi, K; Isobe, T

BMC GERIATRICS Vol. 21 ( 1 ) page： 74 2021.1

PhaseIIclinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors

Nishida, Y; Urakawa, H; Nakayama, R; Kobayashi, E; Ozaki, T; Ae, K; Matsumoto, Y; Tsuchiya, H; Goto, T; Hiraga, H; Naka, N; Takahashi, S; Ando, Y; Ando, M; Kuwatsuka, Y; Hamada, S; Ueda, T; Kawai, A

INTERNATIONAL JOURNAL OF CANCER Vol. 148 ( 1 ) page： 140 - 149 2021.1

　 PREV - NEXT 　

<ANDO Yuichi>

Papers - ANDO Yuichi